Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded
- Contract number
- SPE2DB26FRHKL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,257
Award facts
- Contract value 100% obligated
- $10,256.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes, with a ceiling value of $10,256.76. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, under a firm fixed price delivery order contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen's contract portfolio demonstrates extensive medical product deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FRHKL?
SPE2DB26FRHKL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FRHKL worth?
The government has obligated $10,257 on SPE2DB26FRHKL.
Is contract SPE2DB26FRHKL an order under another contract?
Yes. SPE2DB26FRHKL is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB26FRHKL competed?
The extent of competition for SPE2DB26FRHKL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award